JP Patent

JP7551629B2 — スプライシングを調節するための方法および組成物

Assigned to スカイホーク・セラピューティクス・インコーポレーテッド · Expires 2024-09-17 · 2y expired

What this patent protects

Patent listed against Evrysdi.

Drugs covered by this patent

Evrysdi (RISDIPLAM) · Roche

Patent Metadata

Patent number: JP7551629B2
Jurisdiction: JP
Classification: —
Expires: 2024-09-17
Drug substance claim: No
Drug product claim: No
Assignee: スカイホーク・セラピューティクス・インコーポレーテッド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.